GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Zimmer Holdings, Inc. (ZBH) [hlAlert]

Rating:
Outperform
ZMH
up 97.15 %

Zimmer Holdings, Inc. (ZMH) rated Outperform by Bernstein

Posted on: Friday,  Sep 7, 2012  8:25 AM ET by Bernstein

Bernstein rated Outperform Zimmer Holdings, Inc. (NYSE: ZBH) on 09/07/2012. Previously Bernstein rated Outperform Zimmer Holdings, Inc. (NYSE: ZBH) on 09/21/2009.,
when the stock price was $52.45. Since then, Zimmer Holdings, Inc. has gained 97.16% as of 01/12/2016's recent price of $103.41.
If you would have followed the previous Bernstein's recommendation on ZBH, you would have gained 97.15% of your investment in 2304 days.

Zimmer Holdings, Inc. (Zimmer) designs, develops, manufactures and markets orthopaedic and dental reconstructive implants, spinal implants, trauma products and related surgical products. The Company also provides other healthcare related services. Its primary customers include musculoskeletal surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers and, in their capacity as agents, healthcare purchasing organizations or buying groups. These customers range from large multinational enterprises to independent surgeons. It has operations in more than 25 countries and market products in more than 100 countries. In October 2008, the Company acquired Abbott Spine. It markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and, in the Asia Pacific region, healthcare dealers, and directly to dental practices and dental laboratories.

A central advantage for Bernstein clients is the ability to harness our highly regarded expertise in investment research and management. Originally known as a value investor, Bernstein has long been known for seeking out stocks with temporarily depressed prices due to unwarranted short-term pessimism about a company’s ability to recover from its current problems. This philosophy is embodied in our flagship Strategic Value portfolio. But since value and growth stocks have alternated leadership—with no clear signal of when one style will give way to the other—we’ve developed a Strategic Growth portfolio that seeks out leading companies whose stock prices don’t fully reflect their companies’ potential for superior earnings growth.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/7/2012 8:25 AM Buy
None
64.80
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/21/2009 9:25 AM Buy
None
52.45

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy